Man Group’s Cytokinetics CYTK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-63,696
| Closed | -$3M | – | 1969 |
|
2024
Q4 | $3M | Sell |
63,696
-238,517
| -79% | -$11.2M | 0.01% | 1063 |
|
2024
Q3 | $16M | Buy |
302,213
+227,074
| +302% | +$12M | 0.04% | 485 |
|
2024
Q2 | $4.07M | Sell |
75,139
-7,505
| -9% | -$407K | 0.01% | 995 |
|
2024
Q1 | $5.79M | Buy |
82,644
+74,357
| +897% | +$5.21M | 0.01% | 882 |
|
2023
Q4 | $692K | Buy |
+8,287
| New | +$692K | ﹤0.01% | 1459 |
|
2023
Q3 | – | Sell |
-244,107
| Closed | -$7.96M | – | 1622 |
|
2023
Q2 | $7.96M | Buy |
+244,107
| New | +$7.96M | 0.02% | 701 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 904 |
|
2022
Q3 | – | Hold |
0
| – | -$3.4M | – | 2018 |
|
2022
Q2 | – | Sell |
-52,653
| Closed | -$1.94M | – | 927 |
|
2022
Q1 | $1.94M | Buy |
+52,653
| New | +$1.94M | 0.01% | 1212 |
|
2019
Q1 | – | Sell |
-11,100
| Closed | -$70K | – | 1962 |
|
2018
Q4 | $70K | Sell |
11,100
-2,300
| -17% | -$14.5K | ﹤0.01% | 1859 |
|
2018
Q3 | $132K | Sell |
13,400
-4,900
| -27% | -$48.3K | ﹤0.01% | 2032 |
|
2018
Q2 | $152K | Sell |
18,300
-34,200
| -65% | -$284K | ﹤0.01% | 2033 |
|
2018
Q1 | $378K | Buy |
+52,500
| New | +$378K | ﹤0.01% | 1757 |
|